Kane Biotech Inc.
KNBIF
$0.0643
-$0.002-3.02%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -66.41% | -14.74% | -16.58% | -30.51% | 31.15% |
| Total Receivables | -8.11% | -48.80% | -88.65% | -90.00% | -35.71% |
| Inventory | -8.77% | -18.63% | -69.61% | -66.39% | 17.01% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -32.91% | -29.40% | 1,507.90% | 1,469.78% | 112.28% |
| Total Current Assets | -37.13% | -26.13% | 31.44% | 23.21% | 5.11% |
|
|
|||||
| Total Current Assets | -37.13% | -26.13% | 31.44% | 23.21% | 5.11% |
| Net Property, Plant & Equipment | -20.02% | -22.47% | -17.13% | -12.79% | -5.83% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -10.17% | -12.28% | -11.84% | -9.06% | -1.50% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -64.18% | -63.38% | -55.01% |
| Total Assets | -34.94% | -29.39% | 6.01% | 3.60% | -7.49% |
|
|
|||||
| Total Accounts Payable | 87.74% | -12.10% | -5.31% | -25.71% | -8.34% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -99.87% | -99.85% | 34.62% | 69.62% | 63.75% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.78% | -9.09% | -4.56% | 65.99% | 32.13% |
| Total Finance Division Other Current Liabilities | -31.63% | -8.76% | 187.82% | 138.00% | 27.65% |
| Total Other Current Liabilities | -31.63% | -8.76% | 187.82% | 138.00% | 27.65% |
| Total Current Liabilities | -71.31% | -66.67% | 62.14% | 76.06% | 47.41% |
|
|
|||||
| Total Current Liabilities | -71.31% | -66.67% | 62.14% | 76.06% | 47.41% |
| Long-Term Debt | -24.37% | -25.30% | -21.39% | -16.33% | 1.30% |
| Short-term Debt | -99.87% | -99.85% | 34.62% | 69.62% | 63.75% |
| Capital Leases | -12.73% | -15.12% | -11.81% | -9.06% | -9.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 21.19% | 24.92% | 25.69% |
| Total Liabilities | -64.68% | -60.77% | 40.77% | 47.99% | 33.21% |
|
|
|||||
| Common Stock & APIC | 4.48% | 0.83% | 3.57% | 5.36% | 3.73% |
| Retained Earnings | 17.69% | 19.17% | -13.56% | -16.39% | -13.60% |
| Treasury Stock & Other | -52.49% | 28.05% | -- | -- | -- |
| Total Common Equity | 92.50% | 91.78% | -51.08% | -65.89% | -64.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 92.50% | 91.78% | -51.08% | -65.89% | -64.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -6.20% | -7.66% | -6.03% |
| Total Equity | 90.17% | 88.82% | -75.84% | -108.29% | -113.85% |
|
|
|||||
